Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Inventory (2019 - 2025)

Sunshine Biopharma's Inventory history spans 7 years, with the latest figure at $13.5 million for Q4 2025.

  • For Q4 2025, Inventory rose 19.45% year-over-year to $13.5 million; the TTM value through Dec 2025 reached $13.5 million, up 19.45%, while the annual FY2025 figure was $13.5 million, 19.45% up from the prior year.
  • Inventory reached $13.5 million in Q4 2025 per SBFM's latest filing, down from $14.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $14.1 million in Q3 2025 to a low of $26660.0 in Q1 2021.
  • Average Inventory over 5 years is $5.6 million, with a median of $4.4 million recorded in 2023.
  • Peak YoY movement for Inventory: skyrocketed 3014.0% in 2022, then increased 19.45% in 2025.
  • A 5-year view of Inventory shows it stood at $105650.0 in 2021, then surged by 3014.0% to $3.3 million in 2022, then soared by 74.31% to $5.7 million in 2023, then surged by 96.66% to $11.3 million in 2024, then rose by 19.45% to $13.5 million in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Inventory are $13.5 million (Q4 2025), $14.1 million (Q3 2025), and $13.0 million (Q2 2025).